Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
Lahu S, Adler K, Mayer K, Hein-Rothweiler R, Bernlochner I, Ndrepepa G, Schüpke S, Holdenrieder S, Bongiovanni D, Laugwitz KL, Schunkert H, Gawaz M, Massberg S, Kastrati A, Münch G. Lahu S, et al. Among authors: hein rothweiler r. Thromb Haemost. 2024 Apr;124(4):297-306. doi: 10.1055/s-0043-1772221. Epub 2023 Aug 17. Thromb Haemost. 2024. PMID: 37591289
Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.
Schüpke S, Hein-Rothweiler R, Mayer K, Janisch M, Sibbing D, Ndrepepa G, Hilz R, Laugwitz KL, Bernlochner I, Gschwendtner S, Kupka D, Gori T, Zeiher AM, Schunkert H, Massberg S, Kastrati A; ISAR-PLASTER-Trial Investigators. Schüpke S, et al. Among authors: hein rothweiler r. Thromb Haemost. 2019 Sep;119(9):1539-1545. doi: 10.1055/s-0039-1692423. Epub 2019 Jun 21. Thromb Haemost. 2019. PMID: 31226721
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.
Mayer K, Hein-Rothweiler R, Schüpke S, Janisch M, Bernlochner I, Ndrepepa G, Sibbing D, Gori T, Borst O, Holdenrieder S, Kupka D, Petzold T, Bradaric C, Okrojek R, Leistner DM, Trippel TD, Münzel T, Landmesser U, Pieske B, Zeiher AM, Gawaz MP, Hapfelmeier A, Laugwitz KL, Schunkert H, Kastrati A, Massberg S. Mayer K, et al. Among authors: hein rothweiler r. JAMA Cardiol. 2021 Jul 1;6(7):753-761. doi: 10.1001/jamacardio.2021.0475. JAMA Cardiol. 2021. PMID: 33787834 Free PMC article. Clinical Trial.
Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
Freynhofer MK, Hein-Rothweiler R, Haller PM, Aradi D, Dézsi DA, Gross L, Orban M, Trenk D, Geisler T, Huczek Z, Toth-Gayor GG, Massberg S, Huber K, Sibbing D. Freynhofer MK, et al. Among authors: hein rothweiler r. Thromb Haemost. 2019 Apr;119(4):660-667. doi: 10.1055/s-0038-1677549. Epub 2019 Jan 29. Thromb Haemost. 2019. PMID: 30695790 Clinical Trial.
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Schüpke S, et al. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475799 Clinical Trial.
Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender Substudy.
Gross L, Kupka D, Trenk D, Geisler T, Hadamitzky M, Löw A, Orban M, Huber K, Kiss RG, Merkely B, Huczek Z, Beuthner BE, Hein-Rothweiler R, Baylacher M, Rizas K, Massberg S, Aradi D, Sibbing D, Jacobshagen C. Gross L, et al. Among authors: hein rothweiler r. Thromb Haemost. 2019 Sep;119(9):1527-1538. doi: 10.1055/s-0039-1692441. Epub 2019 Jun 21. Thromb Haemost. 2019. PMID: 31226717 Clinical Trial.
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trial.
Komócsi A, Merkely B, Hadamitzky M, Massberg S, Rizas KD, Hein-Rothweiler R, Gross L, Trenk D, Sibbing D, Aradi D. Komócsi A, et al. Among authors: hein rothweiler r. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):608-616. doi: 10.1093/ehjcvp/pvad027. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37015874 Free PMC article. Clinical Trial.
Percutaneous Decannulation Instead of Surgical Removal for Weaning After Venoarterial Extracorporeal Membrane Oxygenation-A Crossed Perclose ProGlide Closure Device Technique Using a Hemostasis Valve Y Connector.
Lüsebrink E, Stremmel C, Stark K, Petzold T, Hein-Rothweiler R, Scherer C, Schüttler D, Massberg S, Orban M. Lüsebrink E, et al. Among authors: hein rothweiler r. Crit Care Explor. 2019 Jun 26;1(6):e0018. doi: 10.1097/CCE.0000000000000018. eCollection 2019 Jun. Crit Care Explor. 2019. PMID: 32166262 Free PMC article.
Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography.
Orban M, Ulrich S, Dischl D, von Samson-Himmelstjerna P, Schramm R, Tippmann K, Hein-Rothweiler R, Strüven A, Lehner A, Braun D, Hausleiter J, Jakob A, Fischer M, Hagl C, Haas N, Massberg S, Mehilli J, Robert DP. Orban M, et al. Among authors: hein rothweiler r. Int J Cardiol. 2021 Apr 1;328:227-234. doi: 10.1016/j.ijcard.2020.12.025. Epub 2020 Dec 11. Int J Cardiol. 2021. PMID: 33316256
15 results